Ligand Pharmaceuticals | LGND - Ticaret Borçlular





Ticaret Borçlular Değişiklik Tarih
Agenus USD 22.34M 107K 2026-03
Amgen USD 10.23B 1.09B 2026-06
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 8.56M 7.13M 2026-06
Baxter International USD 1.86B 158M 2026-06
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Eli Lilly USD 23.48B 2.3B 2026-06
Enanta Pharmaceuticals USD 40.16M 1.52M 2024-12
Enviri Corporation USD 341.34M 27.84M 2025-12
Gilead Sciences USD 5.06B 314M 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
Glaxosmithkline GBP 10.49B 40.6M 2026-03
Heron Therapeutics USD 89.59M 8.54M 2025-12
Insmed USD 215.32M 36.77M 2026-06
Intrexon USD 1.02M 559K 2024-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Karyopharm Therapeutics USD 23.36M 2.82M 2026-03
Ligand Pharmaceuticals USD 54.8M 6.25M 2026-03
MacroGenics USD 10.42M 2.95M 2026-03
Merck USD 12.21B 435M 2026-03
Pacira USD 132.42M 6.78M 2026-06
Pfizer USD 16.19B 19M 2026-06
Rigel Pharmaceuticals USD 28.9M 1.39M 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Veracyte USD 54.18M 4.06M 2026-06